Search results
The Global Fund invests US$4 billion a year to defeat HIV, TB and malaria and ensure a healthier, safer, equitable future for all. We unite the world to find solutions that have the most impact, and we take them to scale worldwide. It’s working. We won’t stop until the job is finished.
- About the Global Fund
In 2022, the Global Fund disbursed a record US$5.2 billion...
- Staff & Organization
The staff of the Global Fund carry out day-to-day...
- The Global Fund’s Monitoring and Evaluation Framework
The Global Fund Strategy 2023-2028 includes a Key...
- Civil Society
Communities living with and impacted by the three diseases...
- Friends of the Fund
Pacific Friends of Global Health (Pacific Friends) was...
- Implementing Partners
Implementing partners are fundamental to the Global Fund...
- Private Sector & Foundations
Funding is essential to scaling up and winning the fight...
- Technical & Development Partners
The Global Fund is a partnership, based on the core...
- Board
The Board of the Global Fund embodies the partnership...
- Country Coordinating Mechanisms
A Country Coordinating Mechanism – often called a “CCM” –...
- About the Global Fund
- Funding
- Prevention
- Testing and Treatment
The Global Fund provides 65% of all international financing for malaria programs.We have invested more than US$17.9 billion in malaria control programs as of June 2023.Since January 2021, we have increased malaria grants by 23% on average.220 million mosquito nets distributed to protect families from malaria in 2022.8.5 million structures covered by indoor residual spraying in 2022.37.1 million children covered by seasonal malaria chemoprevention in 2022.14.6 million pregnant women received preventive therapy for malaria in 2022.321 million suspected cases of malaria tested in 2022.166 million cases of malaria treated in 2022.Our Response. The Global Fund provides 28% of all international financing for HIV programs and has invested US$25.5 billion in programs to prevent and treat HIV and AIDS and US$4.6 billion in TB/HIV programs as of June 2023. Since 2020, we have also stepped up support to countries to mitigate the impact of COVID-19 on the HIV response.
The Global Fund is the world's largest financier of AIDS, TB, and malaria prevention, treatment, and care programs. [5] As of June 2019, the organization had disbursed more than US$41.6 billion to support these programs. [6] According to the organization, in 2018 it helped finance the distribution of 131 million insecticide-treated nets to ...
The Global Fund provides 76% of all international financing for TB and has invested US$9.2 billion in programs to prevent and treat TB and an additional US$1.5 billion in TB/HIV programs as of June 2023. In countries where the Global Fund invests, TB deaths have dropped by 36% between 2002 and 2022. Without these interventions, TB deaths would ...
Sep 12, 2022 · The Global Fund’s 2022 Results Report released today finds a significant rebound in 2021 for programs working to defeat HIV, tuberculosis (TB) and malaria. In 2020, the COVID-19 pandemic had a devastating impact on the fight against the three diseases, leading to the decline of key programmatic results across the three diseases for the first time in the history of the Global Fund.